Professor, Medicine - Infectious Diseases, Stanford University Medical Center
Infectious Disease
Dr. Julie Parsonnet, MD
|
|
Give Review
Julie Parsonnet, MD works in the field of Infectious Disease. He studied medicine at Weill Cornell Medical College of Cornell University. Weill Cornell Medical College of Cornell University is ranked 18 in research and 49 in primary care medicine He received awards:"CMS Meaningful Use Stage 1 Certification" and "Elected Member". Julie Parsonnet is a published doctor. He has 69 publications published. The most current publication "Epidemiology of gastric non-Hodgkin's lymphoma patients: parallels with Helicobacter pylori." He is registered with Medicare and accepts Medicare payments.
Publications
- Discovery of a novel polyomavirus in acute diarrheal samples from children.
- Infection with Helicobacter pylori is associated with protection against tuberculosis.
- Reproducibility of QuantiFERON-TB gold in-tube assay.
- Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials.
- Helicobacter pylori infection and gastric lymphoma.
- Helicobacter pylori infection and the risk of gastric carcinoma.
- Prevention of gastric cancer.
- Maternal prepregnancy body mass index and risk of spontaneous preterm birth.
- Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers.
- The immune response to tuberculosis infection in the setting of Helicobacter pylori and helminth infections.
- Decreasing intestinal parasites in recent Northern California refugees.
- Infectious diseases in children and body mass index in young adults.
- Investigation of false-positive results given by the QuantiFERON-TB Gold In-Tube assay.
- Gastric Cancer Incidence among Hispanics in California: Patterns by Time, Nativity, and Neighborhood Characteristics.
- The impact of mucosal infections on acquisition and progression of tuberculosis.
- Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection.
- Effect of Helicobacter pylori infection on symptoms of gastroenteritis due to enteropathogenic Escherichia coli in adults.
- Role of bacteria in oncogenesis.
- Immediate incubation reduces indeterminate results for QuantiFERON-TB Gold in-tube assay.
- Vitamin d deficiency and tuberculosis progression.
- Required vs. elective research and in-depth scholarship programs in the medical student curriculum.
- Encouraging scholarship: medical school programs to promote student inquiry beyond the traditional medical curriculum.
- Engaging students in dedicated research and scholarship during medical school: the long-term experiences at Duke and Stanford.
- Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States.
- Interpreting data in the face of competing explanations: assessing the hypothesis that observed spontaneous clearance of Helicobacter pylori was all measurement error.
- The complete genome of klassevirus - a novel picornavirus in pediatric stool.
- Helicobacter species in cancers of the gallbladder and extrahepatic biliary tract.
- Gastroenteritis and transmission of Helicobacter pylori infection in households.
- Concordance of Helicobacter pylori infection among children in extended-family homes.
- Commentary: H. pylori infection in early life and the problem of imperfect tests.
- Use of insecticide-treated nets (ITNs) following a malaria education intervention in Piron, Mali: a control trial with systematic allocation of households.
- QuantiFERON-TB predicts tuberculin skin test boosting in U.S. foreign-born.
- Risk of intestinal helminth and protozoan infection in a refugee population.
- Helicobacter pylori infection in different generations of Hispanics in the San Francisco Bay Area.
- Household transmission of gastroenteritis.
- Significance of transiently positive enzyme-linked immunosorbent assay results in detection of Helicobacter pylori in stool samples from children.
- Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma.
- Helicobacter pylori and risk of gastroenteritis.
- Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States.
- Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial.
- Bacterial infection and MALT lymphoma.
- Helicobacter pylori infection and gastric cancer--for want of more outcomes.
- Natural acquisition of Helicobacter pylori infection in newborn rhesus macaques.
- What is the Helicobacter pylori global reinfection rate?
- Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia.
- C-reactive protein, Helicobacter pylori, Chlamydia pneumoniae, cytomegalovirus and risk for myocardial infarction.
- Diagnostic yield of gastric biopsy specimens when screening for preneoplastic lesions.
- Helicobacter pylori in cathartic stools of subjects with and without cimetidine-induced hypochlorhydria.
- [High frequency of precancerous lesions of gastric cancer associated with Helicobacter pylori and response to treatment, in Chiapas, Mexico].
- Growth slowing after acute Helicobacter pylori infection is age-dependent.
- Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure.
- Helicobacter pylori: consensus and controversy.
- Validation of Spanish language dyspepsia questionnaire.
- CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma.
- Quantifying the population impact of a prophylactic Helicobacter pylori vaccine.
- Confirmatory serologic testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers.
- A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United States.
- Helicobacter pylori vaccine development and use: a cost-effectiveness analysis using the Institute of Medicine Methodology.
- Fecal and oral shedding of Helicobacter pylori from healthy infected adults.
- Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers.
- Helicobacter pylori and gastric cancer: what are the benefits of screening only for the CagA phenotype of H. pylori?
- Risk for gastric lymphoma in persons with CagA+ and CagA- Helicobacter pylori infection.
- Epidemiology of gastric non-Hodgkin's lymphoma patients: parallels with Helicobacter pylori.
- Should we treat H. pylori infection to prevent gastric cancer?
- Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas.
- Comparison of two methods - regression predictive model and intake shift model - for adjusting self-reported dietary recall of total energy intake of populations.
- Urinary Triclosan is Associated with Elevated Body Mass Index in NHANES.
- Safety and acceptability of Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 in Bangladeshi infants: a phase I randomized clinical ...
Schools
Joan Sanford I Weill Medical College Of Cornell University
Massachusetts General Hospital
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Benesys
- Blue Card PPO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Select PPO
- Access Plus Savenet
- Basic Exclusive PPO for Small Business
- Basic PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Covered California - Bronze PPO
- Health Net PPO
- Individual and Family PPO
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
- Elected Member
Education
-
Massachusetts General Hospital -
Weill Cornell Medical College of Cornell University
Hospital
-
VA Palo Alto Health Care System -
Stanford Health Care
Drug Facts
| NPI NUMBER | 1083771646 | |
| NPPES Provider LastName | PARSONNET | |
| NPPES Provider FirstName | JULIE | |
| NPPES Provider ZIPCode | 943052200 | |
| NPPES Provider State | CA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 106.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1083771646 |
| Last Name Of The Provider | PARSONNET |
| First Name Of The Provider | JULIE |
| View All |
Similar Doctors
|
|
Dr. Rena C. Patel, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lucy S. Tompkins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew B. Nevins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alicia H. Chang, MD |
|
|
Dr. Daniel B. Di Giulio, MD |
|
|
Dr. Dora Y. Ho, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shirit Einav, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phillip S. Pang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth V. Robilotti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul R. Waldron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tessa M. Andermann, MD |
|
|
Dr. Janice M. Brown, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Upinder Singh, MD |
|
|
Dr. Patricia L. Schirmer, MD
This Doctor is OpenDoctor Recommended.
|